Trademarkia Logo

Canada

C$
Trademark Search in Canada
ATTRUBY

View On IC.GC.CA

ATTRUBY
APPROVED

on 29 Jan 2025

Last Applicant/ Owned by

Bridgebio Pharma, Inc.

3160 Porter Dr., Suite 250 Palo Alto CA 94304

US

Serial Number

2210079 filed on 18th Aug 2022

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

ATTRUBY

Trademark usage description

pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and diso Read More

Classification Information

Class [005]
Pharmaceuticals for use in the treatment of oncological diseases and disorders, cardiological diseases and disorders, dermatological diseases and disorders, namely, dermatitis, skin pigmentation diseases, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema, and sexually transmitted diseases, neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, and cerebral palsy, genetic diseases and disorders, orthopedic diseases and disorders, namely, arthritis, osteoporosis, fibromyalgia, and metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity, hyperlipidemia, insulin resistance, metabolic syndrome.

Classification kind code

11

Mark Details

Serial Number

2210079

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 135
on 14th Mar 2024		Amendment to Application
Submitted for opposition 22
on 27th Dec 2023		Search Recorded
Submitted for opposition 20
on 27th Dec 2023		Examiner's First Report
Submitted for opposition 223
on 27th Dec 2023		Total Provisional Refusal
Submitted for opposition 256
on 17th Jul 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Sept 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Sept 2022		Created
Submitted for opposition 31
on 14th Sept 2022		Formalized
Submitted for opposition 30
on 18th Aug 2022		Filed
Submitted for opposition 228
on 18th Aug 2022		International Registration